Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals

Abstract Introduction Plasma amyloid β (Aβ) peptides have been previously studied as candidate biomarkers to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. Methods Free and total Aβ42/40 plasma ratios (FP42/40 and TP42/40, respectively) were det...

Full description

Bibliographic Details
Main Authors: Noelia Fandos, Virginia Pérez‐Grijalba, Pedro Pesini, Salvador Olmos, Matías Bossa, Victor L. Villemagne, James Doecke, Christopher Fowler, Colin L. Masters, Manuel Sarasa, AIBL Research Group
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Amyloid β
Plasma amyloid β ratio
Biomarker
Preclinical Alzheimer's disease
β‐Amyloid imaging
Positron emission tomography
Online Access:https://doi.org/10.1016/j.dadm.2017.07.004

Internet

https://doi.org/10.1016/j.dadm.2017.07.004

Similar Items